$251.820.43%-1.10
Quest Diagnostics Inc (DGX)
Date: 2026-10-30 16:00O: 255.14H: 256.99L: 250.95C: 251.82Vol: 915.6k
Quest Diagnostics Inc Azioni (DGX) Dati Finanziari
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues | 1.77%3,097.00 | 3,043.00 | 2,895.00 | 2,806.00 | 2,816.00 |
| Cost Of Revenue | 1.93%2,055.00 | 2,016.00 | 1,953.00 | 1,896.00 | 1,867.00 |
1.13%523.00 | 529.00 | 504.00 | - | - | |
| Selling, General, and Administrative | 1.13%523.00 | 529.00 | 504.00 | - | - |
| Costs And Expenses | 1.32%2,618.00 | 2,584.00 | 2,496.00 | 2,420.00 | 2,430.00 |
| Operating Income/Loss | 4.36%479.00 | 459.00 | 399.00 | 386.00 | 386.00 |
| Net Interest Income/Expense | 3.17%-61.00 | -63.00 | -63.00 | -64.00 | -66.00 |
34.04%-63.00 | -47.00 | -65.00 | -56.00 | -58.00 | |
| Interest And Devidend Income | 20.00%6.00 | 5.00 | 2.00 | 3.00 | 3.00 |
| Income/Loss From Equity Method Investments | 10.00%9.00 | 10.00 | 4.00 | 7.00 | 8.00 |
| Income/Loss From Continuing Operations Before Tax | 0.97%416.00 | 412.00 | 334.00 | 330.00 | 328.00 |
| Income Tax Expense/Benefit, Deferred | 5,550%109.00 | -2.00 | 48.00 | -13.00 | 110.00 |
| Income Tax Expense/Benefit | 12.50%99.00 | 88.00 | 74.00 | 81.00 | 77.00 |
2.40%326.00 | 334.00 | 264.00 | 256.00 | 259.00 | |
| Attributable To Parent | 2.50%312.00 | 320.00 | 252.00 | 245.00 | 245.00 |
| Attributable To Noncontrolling Interest | 14.00 | 14.00 | 12.00 | 11.00 | 14.00 |
| Basic Average Shares | 0.90%110.00 | 111.00 | 110.00 | -1.00 | 112.00 |
| Diluted Average Shares | 112.00 | 112.00 | 112.00 | - | 113.00 |
| Basic Earnings Per Share | 2.08%2.82 | 2.88 | 2.27 | 2.21 | 2.18 |
| Diluted Earnings Per Share | 2.11%2.78 | 2.84 | 2.24 | 2.18 | 2.16 |
| Common Stock Dividends | 0.86 | 0.86 | 0.86 | 0.80 | 0.80 |